B dot Medical is pleased to announce the new executive structure as approved at the Annual General Meeting of Shareholders held on June 13, 2025, and the subsequent Board of Directors meeting.
List of Executives
- Representative Director: Takuji Furukawa (Incumbent), President and CEO, Head of Corporate Management Div.
- Director: Tomohiko Yabu (Incumbent), CTO, Head of R&D Div.
- Director: Takehiro Fujimoto (Newly appointed), CCO, Head of Commercial Div.
- Director (External): Hideyuki Sakurai (Incumbent)
- Auditor (External): Kenichi Tokunaga
- Auditor (External): Tatsuya Nagase
